ReviewMedicina (Kaunas, Lithuania)2022

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes.

Angelo Maria Patti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.